1-8 of 8
Natalia Neparidze
Close
Sort by
Journal Articles

Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence

Rory M. Shallis, Rong Wang, Amer M. Zeidan, Scott F. Huntington, Natalia Neparidze, Jessica M. Stempel, Lourdes M. Mendez, Mengyang Di, Xiaomei Ma, Nikolai A. Podoltsev
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3213–3224.
https://doi.org/10.1182/bloodadvances.2022009074
Published: 2023
Journal Articles

Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis

Mengyang Di, Can Cui, Shalin K. Kothari, Amer M. Zeidan, Nikolai A. Podoltsev, Natalia Neparidze, Rory M. Shallis, Rong Wang, Xiaomei Ma, Scott F. Huntington
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3339–3342.
https://doi.org/10.1182/bloodadvances.2021006934
Published: 2022
Includes: Supplemental data
Journal Articles

Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States

Clinical Trials & Observations
Jan Philipp Bewersdorf, Stephanie Prozora, Nikolai A. Podoltsev, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Rong Wang, Amer M. Zeidan, Amy J. Davidoff
Journal: Blood Advances
Blood Adv (2022) 6 (2): 376–385.
https://doi.org/10.1182/bloodadvances.2021005642
Published: 2022
Includes: Supplemental data
Journal Articles

Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents

Clinical Trials & Observations
Smith Giri, Scott F. Huntington, Rong Wang, Amer M. Zeidan, Nikolai Podoltsev, Steven D. Gore, Xiaomei Ma, Cary P. Gross, Amy J. Davidoff, Natalia Neparidze
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2245–2253.
https://doi.org/10.1182/bloodadvances.2019001425
Published: 2020
Journal Articles

Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States

Clinical Trials & Observations
Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Rory M. Shallis, Nikolai A. Podoltsev, Jan P. Bewersdorf, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2192–2201.
https://doi.org/10.1182/bloodadvances.2020001779
Published: 2020
Includes: Supplemental data
Journal Articles

Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States

Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Chi Zhang, Jan Philipp Bewersdorf, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma, Rong Wang
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1615–1623.
https://doi.org/10.1182/bloodadvances.2020001728
Published: 2020
Journal Articles

Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy

Clinical Trials & Observations
Jithendra Kini Bailur, Sameet Mehta, Lin Zhang, Natalia Neparidze, Terri Parker, Noffar Bar, Tara Anderson, Mina L. Xu, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2343–2347.
https://doi.org/10.1182/bloodadvances.2017012732
Published: 2017
Includes: Supplemental data
Journal Articles

Whole-exome sequencing in evaluation of patients with venous thromboembolism

Eun-Ju Lee, Daniel J. Dykas, Andrew D. Leavitt, Rodney M. Camire, Eduard Ebberink, Pablo García de Frutos, Kavitha Gnanasambandan, Sean X. Gu, James A. Huntington, Steven R. Lentz, Koen Mertens, Christopher R. Parish, Alireza R. Rezaie, Peter P. Sayeski, Caroline Cromwell, Noffar Bar, Stephanie Halene, Natalia Neparidze, Terri L. Parker, Adrienne J. Burns, Anne Dumont, Xiaopan Yao, Cassius Iyad Ochoa Chaar, Jean M. Connors, Allen E. Bale, Alfred Ian Lee
Journal: Blood Advances
Blood Adv (2017) 1 (16): 1224–1237.
https://doi.org/10.1182/bloodadvances.2017005249
Published: 2017